Try our beta test site

PK Study of Oral and IV Clofarabine in High Risk Myelodysplasia+Acute Leukemias

This study has been terminated.
(Drug supply discontinued by Collaborator.)
Sponsor:
Collaborator:
Genzyme, a Sanofi Company
Information provided by (Responsible Party):
UNC Lineberger Comprehensive Cancer Center
ClinicalTrials.gov Identifier:
NCT01169012
First received: July 22, 2010
Last updated: March 10, 2017
Last verified: March 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2013
  Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)